| MR编号 | UK/H/5802/001 |
|---|
| 药品名称 | Paracetamol/Guaifenesin/Phenylephrine Hydrochloride Wrafton 250mg/100mg/5mg Tablets |
|---|
| 活性成分 | - Guaifenesin 100.0 mg
- Paracetamol 250.0 mg
- Phenylephrine hydrochloride 5.0 mg
|
|---|
| 剂型 | Tablet |
|---|
| 上市许可持有人 | Wrafton Laboratories Limited,
Braunton,
Devon,
EX33 2DL |
|---|
| 参考成员国 - 产品名称 | United Kingdom (UK) Paracetamol, Guaifenesin, Phenylephrine HCL 250 mg/100 mg/5 mg Wrafton Film coated tablets |
|---|
| 互认成员国 - 产品名称 | - Czech Republic (CZ)
Paracetamol/Guaifenesin/Phenylephrine Hydrochloride Wrafton Film Coated Tablets - Germany (DE)
Paracetamol/Guaifenesin/Phenylephrinhydrochlorid Wrafton 250 mg/100 mg/5 mg Filmtabletten - Spain (ES)
- Hungary (HU)
- Italy (IT)
- Poland (PL)
Paracetamol+Guaifenesin+Phenylephrine Hydrochloride Wrafton - Romania (RO)
- Slovak Republic (SK)
Paracetamol, Guajfenezín, Fenylefríniumchlorid Wrafton 250 mg/100 mg/5 mg, filmom obalené tablety
|
|---|
| 许可日期 | 2015/11/20 |
|---|
| 最近更新日期 | 2016/03/08 |
|---|
| 药物ATC编码 | - N02BE51 paracetamol, combinations excl. psycholeptics
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Other
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Withdrawn（注：已撤市） 撤市原因：1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised. |
|---|
|
|---|